Therapy Persistence
Therapy Persistence is a clinical metric within specialty pharmacy benefits that quantifies the duration for which a patient continues a prescribed therapy as intended without significant interruption, distinguishing it from adherence by focusing on treatment discontinuation over time.
119
Publications
5.5K
Citations
681
Authors
342
Institutions
Publications per year
2017–2026
46
Parents
119
Amr Saad, Darren M. Ashcroft, Kath Watson et al. · Arthritis Research & Therapy · 2009 · 201 citations · Full text
Andrew P. Yu, Annie Guérin, Diego Ponce de Leon et al. · Journal of Medical Economics · 2011 · 154 citations · Full text
1–5 of 119
681
3
h-index
3
h-index
3
h-index
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico
2 publications · 85 citations
2
h-index
2
h-index
1–5 of 681
342
Amgen (United States)
Thousand Oaks, United States
5 h-index
15 publications
505 citations

Wake Forest University
Winston-Salem, United States
5 h-index
7 publications
131 citations
Heinrich Heine University Düsseldorf
Düsseldorf, Germany
4 h-index
6 publications
225 citations

University of British Columbia
Vancouver, Canada
4 h-index
6 publications
231 citations

McMaster University
Hamilton, Canada
3 h-index
6 publications
151 citations
Novartis (United States)
New York, United States
3 h-index
6 publications
332 citations
Boehringer Ingelheim (United States)
Ridgefield, United States
3 h-index
13 publications
1.7K citations

University of Liverpool
Liverpool, United Kingdom
3 h-index
5 publications
108 citations
1–8 of 342
Repository · 11 publications · 574 citations
11
h-index
CMRO · 7 publications · 179 citations
7
h-index
4 publications · 103 citations
4
h-index
3 publications · 110 citations
3
h-index
3 publications · 80 citations
3
h-index
1–5